These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 29720480)
1. Targeting USP22 Suppresses Tumorigenicity and Enhances Cisplatin Sensitivity Through ALDH1A3 Downregulation in Cancer-Initiating Cells from Lung Adenocarcinoma. Yun X; Zhang K; Wang J; Pangeni RP; Yang L; Bonner M; Wu J; Wang J; Nardi IK; Gao M; Raz DJ Mol Cancer Res; 2018 Jul; 16(7):1161-1171. PubMed ID: 29720480 [TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-specific protease 22 is critical to in vivo angiogenesis, growth and metastasis of non-small cell lung cancer. Zhang K; Yang L; Wang J; Sun T; Guo Y; Nelson R; Tong TR; Pangeni R; Salgia R; Raz DJ Cell Commun Signal; 2019 Dec; 17(1):167. PubMed ID: 31842906 [TBL] [Abstract][Full Text] [Related]
3. USP22 promotes resistance to EGFR-TKIs by preventing ubiquitination-mediated EGFR degradation in EGFR-mutant lung adenocarcinoma. Zhang H; Han B; Lu H; Zhao Y; Chen X; Meng Q; Cao M; Cai L; Hu J Cancer Lett; 2018 Oct; 433():186-198. PubMed ID: 29981430 [TBL] [Abstract][Full Text] [Related]
4. Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway. Shao C; Sullivan JP; Girard L; Augustyn A; Yenerall P; Rodriguez-Canales J; Liu H; Behrens C; Shay JW; Wistuba II; Minna JD Clin Cancer Res; 2014 Aug; 20(15):4154-66. PubMed ID: 24907115 [TBL] [Abstract][Full Text] [Related]
5. [Increased expression of acetaldehyde dehydrogenase in cisplatin-resistant human lung adenocarcinoma A549/DDP cells]. He J; Song X; Yu L; Li J; Qiao Z; Jiu R; Yu B; Liu X Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 May; 31(5):625-9. PubMed ID: 25940289 [TBL] [Abstract][Full Text] [Related]
6. Combination Treatment with All-Trans Retinoic Acid Prevents Cisplatin-Induced Enrichment of CD133+ Tumor-Initiating Cells and Reveals Heterogeneity of Cancer Stem Cell Compartment in Lung Cancer. Moro M; Bertolini G; Pastorino U; Roz L; Sozzi G J Thorac Oncol; 2015 Jul; 10(7):1027-36. PubMed ID: 26020124 [TBL] [Abstract][Full Text] [Related]
7. Loss of H2B monoubiquitination is associated with poor-differentiation and enhanced malignancy of lung adenocarcinoma. Zhang K; Wang J; Tong TR; Wu X; Nelson R; Yuan YC; Reno T; Liu Z; Yun X; Kim JY; Salgia R; Raz DJ Int J Cancer; 2017 Aug; 141(4):766-777. PubMed ID: 28481029 [TBL] [Abstract][Full Text] [Related]
8. ALDH1A3, the Major Aldehyde Dehydrogenase Isoform in Human Cholangiocarcinoma Cells, Affects Prognosis and Gemcitabine Resistance in Cholangiocarcinoma Patients. Chen MH; Weng JJ; Cheng CT; Wu RC; Huang SC; Wu CE; Chung YH; Liu CY; Chang MH; Chen MH; Chiang KC; Yeh TS; Su Y; Yeh CN Clin Cancer Res; 2016 Aug; 22(16):4225-35. PubMed ID: 27076629 [TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-Specific Peptidase 22 Contributes to Colorectal Cancer Stemness and Chemoresistance via Wnt/β-Catenin Pathway. Jiang S; Song C; Gu X; Wang M; Miao D; Lv J; Liu Y Cell Physiol Biochem; 2018; 46(4):1412-1422. PubMed ID: 29689565 [TBL] [Abstract][Full Text] [Related]
10. USP22 promotes tumor progression and induces epithelial-mesenchymal transition in lung adenocarcinoma. Hu J; Yang D; Zhang H; Liu W; Zhao Y; Lu H; Meng Q; Pang H; Chen X; Liu Y; Cai L Lung Cancer; 2015 Jun; 88(3):239-45. PubMed ID: 25907317 [TBL] [Abstract][Full Text] [Related]
11. The Deubiquitinase USP22-Stabilized COL17A1 Promotes Lung Adenocarcinoma Progression. Chen G; Du D; Wang H; Li H Clin Respir J; 2024 Aug; 18(8):e13824. PubMed ID: 39143031 [TBL] [Abstract][Full Text] [Related]
12. Targeting cancer initiating cells by promoting cell differentiation and restoring chemosensitivity via dual inactivation of STAT3 and src activity using an active component of antrodia cinnamomea mycelia. Chang CW; Chen YS; Chen CC; Chan IO; Chen CC; Sheu SJ; Lin TW; Chou SH; Liu CJ; Lee TC; Lo JF Oncotarget; 2016 Nov; 7(45):73016-73031. PubMed ID: 27682875 [TBL] [Abstract][Full Text] [Related]
13. ALDH1A3 upregulation and spontaneous metastasis formation is associated with acquired chemoresistance in colorectal cancer cells. Durinikova E; Kozovska Z; Poturnajova M; Plava J; Cierna Z; Babelova A; Bohovic R; Schmidtova S; Tomas M; Kucerova L; Matuskova M BMC Cancer; 2018 Aug; 18(1):848. PubMed ID: 30143021 [TBL] [Abstract][Full Text] [Related]
14. Targeting ubiquitin-specific protease 22 suppresses growth and metastasis of anaplastic thyroid carcinoma. Zhao HD; Tang HL; Liu NN; Zhao YL; Liu QQ; Zhu XS; Jia LT; Gao CF; Yang AG; Li JT Oncotarget; 2016 May; 7(21):31191-203. PubMed ID: 27145278 [TBL] [Abstract][Full Text] [Related]
15. miRNA 146a promotes chemotherapy resistance in lung cancer cells by targeting DNA damage inducible transcript 3 (CHOP). Tan W; Liao Y; Qiu Y; Liu H; Tan D; Wu T; Tang M; Zhang S; Wang H Cancer Lett; 2018 Aug; 428():55-68. PubMed ID: 29702190 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells. Cheng W; Liu T; Wan X; Gao Y; Wang H FEBS J; 2012 Jun; 279(11):2047-59. PubMed ID: 22498306 [TBL] [Abstract][Full Text] [Related]
17. Knock-down of ubiquitin-specific protease 22 by micro-RNA interference inhibits colorectal cancer growth. Xu H; Liu YL; Yang YM; Dong XS Int J Colorectal Dis; 2012 Jan; 27(1):21-30. PubMed ID: 21773699 [TBL] [Abstract][Full Text] [Related]
18. USP22 knockdown enhanced chemosensitivity of hepatocellular carcinoma cells to 5-Fu by up-regulation of Smad4 and suppression of Akt. Zhang J; Luo N; Tian Y; Li J; Yang X; Yin H; Xiao C; Sheng J; Li Y; Tang B; Li R Oncotarget; 2017 Apr; 8(15):24728-24740. PubMed ID: 28445968 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of USP7 upregulates USP22 and activates its downstream cancer-related signaling pathways in human cancer cells. Zhang K; Sun T; Li W; Guo Y; Li A; Hsieh M; Wang J; Wu J; Arvanitis L; Raz DJ Cell Commun Signal; 2023 Nov; 21(1):319. PubMed ID: 37946202 [TBL] [Abstract][Full Text] [Related]
20. PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1. Yu S; Li Y; Ren H; Zhou H; Ning Q; Chen X; Hu T; Yang L Cancer Chemother Pharmacol; 2021 Feb; 87(2):207-215. PubMed ID: 33221963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]